Shares of marijuana company Canopy Growth were up over 6% on Wednesday after the company said its Spectrum Cannabis unit is teaming up with the Ontario Long Term Care Association (OLTCA) for a pilot that will assess the use of medical marijuana in treating pain and cognitive function in seniors.

OLTCA and Canopy will recruit a group of long-term care homes to perform the study while evaluating quality of life outcomes, caregiver stress and the economic benefits of cannabis adoption. The six-month study will be conducted at some of Ontario’s 630 long-term care homes.

“There is clearly an interest in the long-term care space to explore medical cannabis as an alternative to traditional medications for pain and degenerative cognitive function,” said Canopy co-Chief Executive Mark Zekulin.

“The pilot study we’ve announced today is the first step in developing an evidence-based, best practice approach to medical cannabis that will result in consistent care for thousands of seniors and ultimately improve quality of life and outcomes in long-term care homes.”

Medical cannabis is currently prescribed for residents as appropriate, but it’s still an emerging area,” says Candace Chartier , CEO, Ontario Long Term Care Association.

“Through this partnership and pilot study, we hope to provide more clarity to long-term care clinicians and frontline staff about the use of medical cannabis for residents.”

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Nevada’s Governor is Not Thrilled about the Idea of Pot Cafes
16 September 2017
New Jersey’s Governor Wants Legal Weed By End of The Year
14 March 2018
South Australia To Ban Driving While on Medical Marijuana
26 June 2017